For an option on Biocytogen Pharmaceuticals’ possible first-in-class B7H3/PTK7 BsADC program, Ideaya Biosciences is paying more than $400 million. The...
Read moreThe largest pharmaceutical company in the world based on market value, Eli Lilly, is getting into the nuclear isotope manufacturing...
Read moreThe life sciences industry is going through a big change right now, thanks to the fast growth of new treatments...
Read moreResearch, cooperation, and the sustainability of safe radiopharmaceuticals for clinical application will be aided by a new IAEA radiopharmacy database....
Read moreADCs could lead to better and more efficient treatments in the complex and specialized field of tailored cancer medicines. ADCs...
Read moreBeyond cancer, there are a number of sectors that provide considerable prospects for antibody drug conjugates (ADCs), using their capacity...
Read moreAntibody drug conjugates (ADCs) are the main players in the fields of cancer clinical research and deal-making, with new alliances...
Read moreThe pharmaceutical water market is expected to grow at a compound annual growth rate (CAGR) of 9.3% from 2024 to...
Read moreThe resultant biotech, which the businesses announced on Thursday, would have a pipeline that may produce 10 clinical readouts over...
Read moreThe world is very interested in generative artificial intelligence (GAI), and for good reason. People have a better idea of...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.